New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 9, 2012
05:31 EDTMEDSMedistem appoints biopharmaceutical executive Dr. Alan Lewis as new CEO
Medistem announced the appointment of Dr. Alan Lewis to the position of CEO and Member of the Board. Since January, Dr. Lewis has been functioning in the capacity of Scientific Advisory Board Member for Medistem. Lewis was most recently the CEO of Ambit Biosciences. He currently serves on the board of BioMarin (BMRN) and a number of private biotechnology companies. Medistem has licensed intellectual property from Yale University related to using ERC to treat Type 1 Diabetes, which the company plans to develop into its third area of clinical trials.
News For MEDS From The Last 14 Days
Check below for free stories on MEDS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for MEDS

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use